A new article from The Epoch Times notes the fact that drug regulators and public health agencies have saturated the airways with claims that serious harms following COVID vaccination are “rare.”
But there has been very little scrutiny of that claim by the media, and the author says that they couldn’t find an instance where international agencies actually quantified what they meant by the term “rare” or provided a scientific source.
A recent study conducted by independent researchers and published in a highly respected vaccinology journal provides the strongest evidence yet for the mRNA vaccines. The study analyzed the original trial data and found that serious adverse events (SAE), which require hospitalization, occurred at an alarming rate in the vaccine arm – with one additional SAE for every 556 people vaccinated with Pfizer’s mRNA vaccine. While drug regulators categorize SAEs occurring at a rate of 1 in 556 as “uncommon,” they are still more frequent than what the general public has been informed.
Therefore, the author said that they asked eight drug regulators and public health agencies to answer a simple question: “What is the official calculated rate of SAEs believed to be caused by Pfizer’s mRNA vaccine, and what is the evidence?”
The agencies were the FDA, TGA, MHRA, HC, PEI, CDC, ECDC, and EMA.
The outcome was startling.
What Is the Official SAE Rate?
The author said that they had reached out to various agencies to inquire about the Serious Adverse Event (SAE) rate of Pfizer’s vaccine, but none of them were able to provide a specific number. Instead, they directed me to pharmacovigilance data and cautioned that it does not establish causation. For instance, the Australian TGA directed me to the spontaneous reporting system but noted that these data cannot be used to accurately calculate the true incidence of adverse events due to the system’s limitations. Similarly, both the German regulator (PEI) and European CDC referred me to the European Medicines Agency, which reported no increase in SAEs.
“SAEs occurred at a low frequency in both vaccinated and the placebo group at 0.6 percent.”
The UK regulator MHRA went so far as to state it “does not make estimations of a serious adverse event (SAE) rate, or a rate for adverse reactions considered to be causally related for any medicinal product.”
The U.S. FDA, on the other hand, conceded that SAEs after mRNA vaccination have “indeed been higher than that of influenza vaccines,” but suggested it was justified because “the severity and impact of covid-19 on public health have been significantly higher than those of seasonal influenza.”
Joe Fraiman, an emergency doctor and the lead author on the reanalysis, responded to criticism by stating that he is not surprised that agencies have not determined the rate of SAEs. According to Fraiman, once these agencies approve a drug, they have no incentive to monitor any resulting harms. He believes that it is hypocritical for health agencies to claim that the serious harms of COVID vaccines are rare when they have not determined the SAE rate themselves.
“It’s very dangerous not to be honest with the public,” said Fraiman, who recently called for the mRNA vaccines to be suspended.